BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia (Q37329157)

19 August 2017

1 reference

title

BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia (English)

1 reference

19 August 2017

0 references

1 reference

1

Janusz K Rybakowski

1 reference

PubMed ID

19018714

19 August 2017

language of work or name

1 reference

1 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

9

1 reference

19 August 2017

11

1 reference

19 August 2017

1589-1593

1 reference

trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor

19 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Role for brain-derived neurotrophic factor in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Neurotrophin-3: a neurotrophic factor related to NGF and BDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

BDNF in schizophrenia, depression and corresponding animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Brain-derived neurotrophic factor val66met polymorphism affects prefrontal energy metabolism in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Illness-specific association of val66met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Decreased serum brain-derived neurotrophic factor levels in major depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: evidence from Belgian first and replication patient-control studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Association study of a brain‐derived neurotrophic‐factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Brain-derived neurotrophic factor (BDNF) gene not associated with antidepressant-induced mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

BDNF gene is a risk factor for schizophrenia in a Scottish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.11.1589

10.2217/14622416.9.11.1589

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

19018714